TY - JOUR
T1 - Congenital immunodeficiency in an individual with Wiedemann–Steiner syndrome due to a novel missense mutation in KMT2A
AU - Stellacci, Emilia
AU - Onesimo, Roberta
AU - Bruselles, Alessandro
AU - Pizzi, Simone
AU - Battaglia, Domenica Immacolata
AU - Leoni, Chiara
AU - Zampino, Giuseppe
AU - Tartaglia, Marco
PY - 2016
Y1 - 2016
N2 - Wiedemann–Steiner Syndrome (WSS) is an autosomal dominant disorder characterized by hypertrichosis, short stature, intellectual disability, developmental delay, and facial dysmorphism. Since the original reports by Wiedemann and co-workers, and Steiner and Marques, only a few cases have been described. Recently, the clinical variability of the disorder has more precisely been characterized by Jones and co-workers, who also identified heterozygous KMT2A mutations as the molecular defect underlying this condition. Here, we report on a boy with a complex phenotype overlapping WSS but exhibiting epilepsy, feeding difficulties, microcephaly, and congenital immunodeficiency with low levels of immunoglobulins as additional features. Whole exome sequencing allowed identifying a previously unreported de novo KMT2A missense mutation affecting the DNA binding domain of the methyltransferase. This finding expands the clinical phenotype associated with KMT2A mutations to include immunodeficiency and epilepsy as clinically relevant features for this disorder. © 2016 Wiley Periodicals, Inc.
AB - Wiedemann–Steiner Syndrome (WSS) is an autosomal dominant disorder characterized by hypertrichosis, short stature, intellectual disability, developmental delay, and facial dysmorphism. Since the original reports by Wiedemann and co-workers, and Steiner and Marques, only a few cases have been described. Recently, the clinical variability of the disorder has more precisely been characterized by Jones and co-workers, who also identified heterozygous KMT2A mutations as the molecular defect underlying this condition. Here, we report on a boy with a complex phenotype overlapping WSS but exhibiting epilepsy, feeding difficulties, microcephaly, and congenital immunodeficiency with low levels of immunoglobulins as additional features. Whole exome sequencing allowed identifying a previously unreported de novo KMT2A missense mutation affecting the DNA binding domain of the methyltransferase. This finding expands the clinical phenotype associated with KMT2A mutations to include immunodeficiency and epilepsy as clinically relevant features for this disorder. © 2016 Wiley Periodicals, Inc.
KW - Genetics
KW - Genetics (clinical)
KW - KMT2A
KW - Weidemann–Steiner syndrome
KW - congenital immunodeficiency
KW - exome sequencing
KW - Genetics
KW - Genetics (clinical)
KW - KMT2A
KW - Weidemann–Steiner syndrome
KW - congenital immunodeficiency
KW - exome sequencing
UR - http://hdl.handle.net/10807/95322
UR - http://onlinelibrary.wiley.com/journal/10.1002/(issn)1552-4833
U2 - 10.1002/ajmg.a.37681
DO - 10.1002/ajmg.a.37681
M3 - Article
SN - 1552-4825
VL - 170
SP - 2389
EP - 2393
JO - AMERICAN JOURNAL OF MEDICAL GENETICS. PART A
JF - AMERICAN JOURNAL OF MEDICAL GENETICS. PART A
ER -